The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs.

By S. Cosgrove. Clinical Infectious Diseases, 2006

1,261 citations recorded by the source corpus.

Subfields: Genetics, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/b245ca91b619feba7c4af67c144366e42fd6103e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Genetics

In Public Health, Environmental and Occupational Health

Citations in the corpus

Statistical physics of vaccination (2016, background): “Indeed, nosocomial infections are a major problem for the safety and health of patients and induce high economical costs [720].”
'My five moments for hand hygiene': a user-centred design approach to understand, train, monitor and report hand hygiene. (2007, background): “Healthcare-associated infections (HCAIs) represent a major risk to patient safety and contribute towards suffering, prolongation of hospital stay, cost and mortality.(1,2) Hand hygiene is the core element to protect patients against HCAIs and colonisation with multi-resistant micro-organisms.”
Hospital Epidemiology and Infection Control in Acute-Care Settings (2011, background): “Infections due to antibiotic-resistant bacteria lead to increased morbidity, mortality, and hospital costs (75, 137).”
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. (2007, result): “Similar adverse outcomes have also been reported for infections with resistant gramnegative organisms, including Pseudomonas, Acinetobacter, and Enterobacter species and extended-spectrum b-lactamase– producing organisms [41].”
Extended-Spectrum β-Lactamase Genes of Escherichia coli in Chicken Meat and Humans, the Netherlands (2011, background): “I with drug-resistant bacteria are associated with higher rates of illnesses and deaths, which have a serious effect on costs of health care (1,2).”
Phage Therapy in the Postantibiotic Era (2019, background): “From an oversimplified description, patients with MDR infections have poorer prognoses, higher mortality rates, lengthier hospital stays, higher risks of complications or permanent sequelae, and increased treatment failure compared with their counterparts with antibiotic-sensitive infections (7, 13,”
Summary of the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship (2007, result): “Similar adverse outcomes have also been reported for infections with resistant gramnegative organisms, including Pseudomonas, Acinetobacter, and Enterobacter species and extended-spectrum b-lactamase– producing organisms [41].”